These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35643422)

  • 41. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total pancreatectomy for recurrent intraductal papillary mucinous carcinoma in remnant pancreas of pancreaticoduodenectomy for intraductal papillary mucinous adenocarcinoma.
    Ohkura Y; Sasaki K; Matsuda M; Hashimoto M
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23709152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms.
    Frankel TL; LaFemina J; Bamboat ZM; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Allen PJ
    HPB (Oxford); 2013 Oct; 15(10):814-21. PubMed ID: 23782351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
    Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
    Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
    Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
    Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
    [No Abstract]   [Full Text] [Related]  

  • 47. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study.
    Moriya T; Traverso W
    Arch Surg; 2012 Jun; 147(6):528-34. PubMed ID: 22351878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
    Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
    Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making.
    Marchegiani G; Crippa S; Perri G; Rancoita PMV; Caravati A; Belfiori G; Dall'Olio T; Aleotti F; Partelli S; Bassi C; Falconi M; Salvia R
    Ann Surg Oncol; 2022 May; 29(5):3206-3214. PubMed ID: 35072863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Kurita Y; Koda H; Toriyama K; Onishi S; Ishihara M; Tanaka T; Tajika M; Niwa Y
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31117111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).
    Sereni E; Luchini C; Salvia R; Pea A
    Chin Clin Oncol; 2019 Apr; 8(2):21. PubMed ID: 31070041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A Resected Case of Intraductal Pupillary Mucinous Neoplasm of the Pancreas Characterized by Recurrence in the Remnant Pancreas and Multiple Malignant Neoplasms in Other Organs].
    Yoshioka R; Tomimaru Y; Noguchi K; Nagase H; Hamabe A; Hirota M; Oshima K; Tanida T; Kawase T; Morita S; Imamura H; Iwazawa T; Akagi K; Adachi S; Dono K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1782-1784. PubMed ID: 28133130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy.
    Mori Y; Ohtsuka T; Tamura K; Ideno N; Aso T; Kono H; Nagayoshi Y; Ueda J; Takahata S; Aishima S; Ookubo F; Oda Y; Tanaka M
    Surgery; 2014 Jan; 155(1):67-73. PubMed ID: 24183345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
    Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraductal papillary mucinous neoplasms of the pancreas.
    Lai EC; Lau WY
    Surgeon; 2005 Oct; 3(5):317-24. PubMed ID: 16245650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?
    Miyazaki M; Yoshitomi H; Shimizu H; Ohtsuka M; Yoshidome H; Furukawa K; Takayasiki T; Kuboki S; Okamura D; Suzuki D; Nakajima M
    Surgery; 2014 Jan; 155(1):58-66. PubMed ID: 24238124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: clinicopathological features and long-term outcomes following a pancreatectomy.
    Antoñanzas J; Cienfuegos JA; Hurtado-Pardo L; Panadero P; Benito A; Pardo F; Rotellar F; Martí-Cruchaga P; Zozaya G; Valentí V; Hernández Lizoain JL
    Rev Esp Enferm Dig; 2018 Dec; 110(12):768-774. PubMed ID: 30168337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Independent predictors of secondary invasive pancreatic remnant tumors after initial resection of an intraductal papillary mucinous neoplasm: a nationwide large-scale survey in Japan.
    Takigawa Y; Kitago M; Matsui J
    Surg Today; 2020 Dec; 50(12):1672-1680. PubMed ID: 32661567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms.
    Kamata K; Takenaka M; Minaga K; Omoto S; Miyata T; Yamao K; Imai H; Nakai A; Tanaka H; Chiba Y; Watanabe T; Sakurai T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kitano M; Kudo M
    Dig Endosc; 2018 Sep; 30(5):659-666. PubMed ID: 29675938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.